Argon Medical Devices
7
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
28.6%
2 terminated/withdrawn out of 7 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
Role: lead
CLEANer Aspiration for Pulmonary Embolism
Role: lead
Abdominal aBscess Catheter Sclerotherapy (ABCS)
Role: collaborator
Achieving Portal Access With Scorpion Post-Approval Study 2
Role: lead
Achieving Portal Access With Scorpion Post-Approval Study (APASS)
Role: lead
Balloon Assisted Maceration Versus Rotational Thrombectomy in Dialysis Access Salvage
Role: collaborator
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
Role: collaborator
All 7 trials loaded